Recent ESC guidelines to identify HCM patients at high risk for sudden death unreliable

Recently, the European Society of Cardiology published new guidelines advancing an equation as the best way to determine which hypertrophic cardiomyopathy patients should receive an implantable cardioverter-defibrillator. However, a study conducted by US and Canadian investigators challenges the ESC Guidelines. Their research found that the ESC sudden death risk score method did not perform effectively in reliably identifying the high-risk patients who need ICDs for the prevention of sudden deat...